Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Retained Earnings (2019 - 2025)

Bioadaptives' Retained Earnings history spans 7 years, with the latest figure at -$10.7 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$10.7 million for Q4 2025, down 17.0% from a year ago — trailing twelve months through Dec 2025 was -$10.7 million (down 17.0% YoY), and the annual figure for FY2025 was -$10.7 million, down 17.0%.
  • Retained Earnings for Q4 2025 was -$10.7 million at Bioadaptives, down from -$9.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$6.1 million in Q1 2021 to a low of -$10.7 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$8.0 million (2023), against an average of -$8.1 million.
  • The sharpest move saw Retained Earnings decreased 22.04% in 2021, then fell 6.28% in 2023.
  • Year by year, Retained Earnings stood at -$6.7 million in 2021, then decreased by 13.45% to -$7.6 million in 2022, then dropped by 9.43% to -$8.3 million in 2023, then fell by 10.88% to -$9.2 million in 2024, then fell by 17.0% to -$10.7 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$10.7 million, -$9.9 million, and -$9.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.